Swiss Rockets

23/09/2022

RocketVax AG Announces New Milestones in the Development of Second-Generation COVID-19 Vaccines

Since the SARS-CoV-2 virus is here to stay and will continue to mutate, research and development of effective vaccines must continue as a high priority. Prof. Volker Thiel’s research group at the Institute of Virology and Immunology and the University of Bern is developing vaccines with an attenua...

02/08/2022

Swiss Rockets AG completes its leadership team by hiring Dr. Milan Crnogorac as Chief Technology Officer as of 1 August 2022.

30/06/2022

Renowned oncologist, researcher, and Chairman of the Oncology Advisory Committee of Swiss Rockets joins Cleveland Clinic from Mayo Clinic.

16/06/2022

RocketVax SARS-CoV-2 Vaccine (RVX-sCPD9) Significantly Outperforms mRNA and Adenovirus Vector-Based Technologies in Animal Models

RocketVax's live-attenuated SARS-CoV-2 vaccine, RVX-sCPD9, exhibits superior efficacy compared to the existing mRNA and viral vector vaccines in animal models. The data shows that RVX-sCPD9 has critical advantages over available COVID-19 vaccines. It elicits robust immunity following single-dose vaccination and a booster following mRNA prime vaccination.

➡️ To read the full article visit www.swissrockets.com/news

17/04/2022

We wish you a very happy Easter! 🍀🍀🍀

07/04/2022

The theme for this year’s World Health Day is “Our Planet, Our Health". Amid the ongoing pandemic and pollution growing on the planet, diseases like cancer, asthma, and heart diseases are increasing rapidly. World Health Organization aims to focus global attention on the urgent actions needed to “keep humans and the planet healthy.”

08/03/2022

Every life begins with a woman. Respect and encourage every woman for what she is. Woman, you are always loved and appreciated. Happy Women’s Day! 🌷

22/12/2021

Dear friends,
The end of the year is a time of year for remembrance. We take stock of where we came from and have a moment to think about where we are going, as we pursue the future with hope. May your new year be all that you hope for, and may it be sprinkled with love and friendship. Happy Holidays! 🎄✨🍀
🇨🇭

18/11/2021

Swiss Rockets AG announces today the appointment of Albert Muntane Casanova as Chief Financial Officer of Swiss Rockets Group.
Mr. Albert Muntane Casanova started as the Chief Financial Officer for all the Swiss Rockets group companies. He is responsible for the finance, strategy, and investment functions.
To read the full biography, click on the link below. 👇

Swiss Rockets AG announces today the appointment of Albert Muntane Casanova as Chief Financial Officers of Swiss Rockets Group. Mr. Albert Muntane Casanova (47) started as the Chief Financial Officer for all the Swiss Rockets group companies. He is responsible for the finance, strategy, and investme...

12/11/2021

Dr Vladimir Cmiljanovic, CEO and founder of Swiss Rockets AG and RocketVax AG, has been named as the recipient of the 2021 Nikola Tesla Award for his accomplishments in the field of science.

Nikola Tesla Award is a prestigious, national award given by the Government of the Republic of Serbia and the Ministry of Foreign Affairs. The laureates of this award are prominent individuals of Serbian origin who have contributed to the promotion of Serbia and strengthening of ties between the motherland and Serbs in the region and the diaspora.

Dr. Vladimir Cmiljanovic has been named as the recipient of the Nikola Tesla Award for advocating the achievements of Serbian scientists in the world through his scientific attainments in the field of oncology, as well as for leading the team of experts in the development of the second generation of SARS-CoV-2 vaccine.
Congratulations! 👏👏👏

Dr. Vladimir Cmiljanovic, CEO and founder of Swiss Rockets AG and RocketVax AG, both domiciled in Basel, Switzerland, has been named as the recipient of the 2021 Nikola Tesla Award for his accomplishments in the field of science. Nikola Tesla Award is a prestigious, national award given by the Gover...

12/08/2021

Congratulations to Dr. Alex A. Adjei, Chairman of the Oncology Advisory Committee of Swiss Rockets, for being named as the recipient of the 2021 ESMO - European Society for Medical Oncology Lifetime Achievement Award. This extraordinary recognition of his accomplishments follows his 2020 Adi F. Gazdar IASLC Merit Award. 👏👏👏

Prof. Dr. Alex A. Adjei, Chairman of the Oncology Advisory Committee of Swiss Rockets, has been named as the recipient of the 2021 ESMO Lifetime Achievement Award. This extraordinary recognition of his accomplishments follows his 2020 Adi F. Gazdar IASLC Merit Award. The prestigious ESMO Lifetime Ac...

03/08/2021

RocketVax has successfully secured CHF 7.2 million in its Seed A financing to fund the pre-clinical development of its Covid-19 vaccine.
Renowned institutional and private investors have funded this financing round. RocketVax is now launching the Seed B financing to fund the first phase of clinical development in humans.
Click on the link below to find out more. 👇

RocketVax has successfully secured CHF 7.2 million in its Seed A financing to fund the pre-clinical development of its Covid-19 vaccine. Renowned institutional and private investors have funded this financing round. RocketVax is now launching the Seed B financing to fund the first phase of clinical....

06/07/2021

Today, Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines based on breakthrough genetic engineering. Under the agreement, Batavia will develop the clinical process and deliver clinical product of RocketVax’s vaccine candidate agai...

17/06/2021

Basel government approves one million for research to develop novel vaccine against SARS-CoV-2 coronavirus.
Basel University Hospital, the University of Basel, and the Swiss Tropical and Public Health Institute have agreed to collaborate with the company RocketVax and jointly advance research to develop a novel vaccine against the SARS-CoV-2 coronavirus.
Click on the link below and read the full article. ⬇️

Basel University Hospital, the University of Basel and the Swiss Tropical and Public Health Institute have agreed to collaborate with the company RocketVax and jointly advance research to develop a novel vaccine against the SARS-CoV-2 coronavirus. The University Hospital Basel (USB), the University....

08/06/2021

How does a Swiss biotech start-up turn Europe into its “Family & Friends” investors?
CEO of RocketVax and Swiss Rockets gave an interview to daura AG.

Wie macht ein Schweizer Bio-Tech Start-up ganz Europa zu seinen «Family & Friends» - Investoren?

04/06/2021

RocketVax AG and Swiss Rockets AG have recruited additional experts to join their scientific and leadership teams to accelerate the development of the SARS-CoV-2 vaccine RVX-13 and to position the companies for the future.
Experts in immunology, cell culture development, cell culture manufacturing, regulatory affairs and quality assurance, legal affairs, and finance join the current team of specialists.
To read the full article, click on the link below. 👇👇👇

RocketVax AG and Swiss Rockets AG have recruited additional experts to join their scientific and leadership teams to accelerate the development of the SARS-CoV-2 vaccine RVX-13 and to position the companies for the future. Swiss Rockets AG founded the subsidiary RocketVax AG in 2020 to develop a nex...

16/04/2021

So proud to announce that Innosuisse, the Swiss Innovation Agency, supports our mission of developing a safe and effective SARS-CoV-2 vaccine - RVX-13.
The support provided by Innosuisse confirms the validity of our innovative research approach. For the team, this support represents an important milestone on the road to successfully achieving the project’s aim of creating a next-generation SARS-CoV-2 vaccine.

When the ongoing coronavirus pandemic broke out at the start of 2020, Swiss Rockets AG set itself the challenge of manufacturing a vaccine that activates multiple lines of immune system defense to combat SARS-CoV-2 most effectively. To achieve this mission, it founded the Basel-based subsidiary Rock...

07/04/2021

Todаy we celebrate . 🌍 🩺
From its inception in 1948, the celebration has aimed to create awareness of a specific health theme to highlight a priority area of concern for the World Health Organization.

The theme for World Health Day 2021 is ''building a fairer, healthier world“. Stating that our world is unequal, WHO remarked that the COVID-19 pandemic has highlighted how some people can have better access to health services and live healthier lives than others.

Being aware of this fact, we put all our strength and expertise to make sure that all people, across the world, have fair and impartial access to quality healthcare.
Join us in building a fairer, healthier world for everyone, everywhere. It's time for to reach ! 🌏 ❤️ 🍀